BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26491350)

  • 41. Bevacizumab helped resolve pericardial and pleural effusion that was associated with malignant ovarian clear cell carcinoma.
    Ueda T; Tsubamoto H; Eguchi A; Terada T; Shibahara H
    Gynecol Oncol Rep; 2016 Apr; 16():11-3. PubMed ID: 27331128
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pericardial Effusion With Tamponade in Lung Cancer Patients During Treatment With Nivolumab: A Report of Two Cases.
    Yamasaki M; Daido W; Saito N; Funaishi K; Okada T; Kawamoto K; Matsumoto Y; Matsumoto N; Taniwaki M; Ohashi N; Hattori N
    Front Oncol; 2019; 9():4. PubMed ID: 30723699
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation and management of pericardial effusion in patients with neoplastic disease.
    Maisch B; Ristic A; Pankuweit S
    Prog Cardiovasc Dis; 2010; 53(2):157-63. PubMed ID: 20728703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Malignant pericardial effusion with cardiac tamponade in ovarian adenocarcinoma.
    Petersen EE; Shamshirsaz AA; Brennan TM; Demetroulis EM; Goodheart MJ
    Arch Gynecol Obstet; 2009 Oct; 280(4):675-8. PubMed ID: 19225795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tetracycline sclerosis in the management of malignant pericardial effusion.
    Shepherd FA; Ginsberg JS; Evans WK; Scott JG; Oleksiuk F
    J Clin Oncol; 1985 Dec; 3(12):1678-82. PubMed ID: 4067615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignant pericardial effusion secondary to ovarian adenocarcinoma: a case report.
    Micha JP; Goldstein BH; Zusman D; Rettenmaier MA; Epstein HD; Brown JV
    J Reprod Med; 2007 Oct; 52(10):971-3. PubMed ID: 17977179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrapericardial steroid treatment for recurrent pericardial effusion in a patient with acute lymphoblastic Leukaemia.
    Mainzer G; Zaidman I; Hatib I; Lorber A
    Hematol Oncol; 2011 Dec; 29(4):220-1. PubMed ID: 21308722
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intrapericardial instillation of cisplatin in a patient with a large malignant effusion.
    Markman M; Howell SB
    Cancer Drug Deliv; 1985; 2(1):49-52. PubMed ID: 4052925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intrapericardial bleomycin for the management of cardiac tamponade secondary to malignant pericardial effusion.
    Cormican MC; Nyman CR
    Br Heart J; 1990 Jan; 63(1):61-2. PubMed ID: 1690021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Massive pericardial effusion due to intrapericardial mixed germ cell tumor in a premature baby.
    Doksöz Ö; Terek DT; Karaçelik M; Yıldırım HT; Demirağ B; Meşe T; Sarıosmanoğlu ON; Arslanoğlu S
    Pediatr Int; 2015 Oct; 57(5):968-70. PubMed ID: 26147709
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tenecteplase for malignant pericardial effusion.
    Johnson KK; Soundarraj D; Patel P
    Pharmacotherapy; 2007 Feb; 27(2):303-5. PubMed ID: 17253921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effective Treatment for Malignant Pleural Effusion and Ascites with Combined Therapy of Bevacizumab and Cisplatin.
    Jiang L; Li P; Gong Z; Hu B; Ma J; Wang J; Chu H; Zhang L; Sun P; Chen J
    Anticancer Res; 2016 Mar; 36(3):1313-8. PubMed ID: 26977031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Women and pericardial neoplastic manifestations of the heart and pericardium].
    Kisselbach C; Ristic AD; Pankuweit S; Karatolius K; Maisch B
    Herz; 2005 Aug; 30(5):409-15; quiz 429-30. PubMed ID: 16132244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The efficacy and safety of complete pericardial drainage by means of intrapericardial fibrinolysis for the prevention of complications of pericardial effusion: a systematic review protocol.
    Kakia A; Wiysonge CS; Ochodo EA; Awotedu AA; Ristic AD; Mayosi BM
    BMJ Open; 2016 Jan; 6(1):e007842. PubMed ID: 26733562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Case report: malignant pericardial effusion as the initial manifestation of malignancy.
    Fincher RM
    Am J Med Sci; 1993 Feb; 305(2):106-10. PubMed ID: 8427291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical presentation and cytopathologic features of malignant pericardial cytology: a single institution analysis spanning a 29-year period.
    Zhu H; Booth CN; Reynolds JP
    J Am Soc Cytopathol; 2015; 4(4):203-209. PubMed ID: 31051755
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrapericardial administration of cisplatin in treatment of metastatic pericardial involvement in adenocarcinoma of the lung.
    Tomkowski WZ; Filipecki S
    Monaldi Arch Chest Dis; 1997 Jun; 52(3):221-4. PubMed ID: 9270245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intrapericardial minocycline sclerosis for malignant pericardial effusion.
    Lashevsky I; Ben Yosef R; Rinkevich D; Reisner S; Markiewicz W
    Chest; 1996 Jun; 109(6):1452-4. PubMed ID: 8769492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion.
    Okamoto H; Shinkai T; Yamakido M; Saijo N
    Cancer; 1993 Jan; 71(1):93-8. PubMed ID: 8416732
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bevacizumab for ramucirumab refractory malignant pleural effusion in non-small cell lung cancer: a case report and review of the literature.
    Mori R; Fujimoto D; Ito M; Tomii K
    Oncotarget; 2017 Jul; 8(29):48521-48524. PubMed ID: 28591698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.